These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 15701408

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. 186Re-liposome labeling using 186Re-SNS/S complexes: in vitro stability, imaging, and biodistribution in rats.
    Bao A, Goins B, Klipper R, Negrete G, Phillips WT.
    J Nucl Med; 2003 Dec; 44(12):1992-9. PubMed ID: 14660726
    [Abstract] [Full Text] [Related]

  • 23. Synthesis and preliminary biological studies of the novel conjugate 188Re-labeled meso-tetrakis(4-sulfophenyl)porphyrin in mice.
    Jia Z, Deng H, Pu M.
    Nucl Med Biol; 2007 Aug; 34(6):643-9. PubMed ID: 17707804
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. 188Re-labeled MPEG-modified superparamagnetic nanogels: preparation and targeting application in rabbits.
    Sun H, Zhang L, Zhang X, Zhang C, Wei Z, Yao S.
    Biomed Microdevices; 2008 Apr; 10(2):281-7. PubMed ID: 17940906
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Preparation and evaluation of rhenium-188-pamidronate as a palliative treatment in bone metastasis.
    Erfani M, Rahmani N, Doroudi A, Shafiei M.
    Nucl Med Biol; 2017 Jun; 49():1-7. PubMed ID: 28279906
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Design, synthesis, and evaluation of [188Re]organorhenium-labeled antibody fragments with renal enzyme-cleavable linkage for low renal radioactivity levels.
    Uehara T, Koike M, Nakata H, Hanaoka H, Iida Y, Hashimoto K, Akizawa H, Endo K, Arano Y.
    Bioconjug Chem; 2007 Jun; 18(1):190-8. PubMed ID: 17226973
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Development of [(90)Y]DOTA-conjugated bisphosphonate for treatment of painful bone metastases.
    Ogawa K, Kawashima H, Shiba K, Washiyama K, Yoshimoto M, Kiyono Y, Ueda M, Mori H, Saji H.
    Nucl Med Biol; 2009 Feb; 36(2):129-35. PubMed ID: 19217524
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Therapeutic effects of a 186Re-complex-conjugated bisphosphonate for the palliation of metastatic bone pain in an animal model.
    Ogawa K, Mukai T, Asano D, Kawashima H, Kinuya S, Shiba K, Hashimoto K, Mori H, Saji H.
    J Nucl Med; 2007 Jan; 48(1):122-7. PubMed ID: 17204708
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.